Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Strategic Partners A/S Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | DKK 137.50 |
52 Week High | DKK 181.50 |
52 Week Low | DKK 89.50 |
Beta | 0.079 |
11 Month Change | -7.41% |
3 Month Change | 27.31% |
1 Year Change | 28.75% |
33 Year Change | -96.14% |
5 Year Change | -97.94% |
Change since IPO | -97.76% |
Recent News & Updates
Recent updates
Shareholder Returns
1TB0 | DE Biotechs | DE Market | |
---|---|---|---|
7D | -7.4% | -3.1% | -1.0% |
1Y | 28.7% | -15.2% | 16.1% |
Return vs Industry: 1TB0 exceeded the German Biotechs industry which returned -13.7% over the past year.
Return vs Market: 1TB0 exceeded the German Market which returned 18.1% over the past year.
Price Volatility
1TB0 volatility | |
---|---|
1TB0 Average Weekly Movement | 12.3% |
Biotechs Industry Average Movement | 6.2% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 10.8% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 1TB0's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 1TB0's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 1 | Jakob Bendtsen | www.strategic-partners.dk |
Strategic Partners A/S does not have significant operations. Previously, it was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024.
Strategic Partners A/S Fundamentals Summary
1TB0 fundamental statistics | |
---|---|
Market cap | €5.30m |
Earnings (TTM) | -€1.53m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-3.5x
P/E RatioIs 1TB0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1TB0 income statement (TTM) | |
---|---|
Revenue | DKK 0 |
Cost of Revenue | DKK 0 |
Gross Profit | DKK 0 |
Other Expenses | DKK 11.42m |
Earnings | -DKK 11.42m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -273.69 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0% |
How did 1TB0 perform over the long term?
See historical performance and comparison